Search | IOVS | ARVO Journals

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Metastatic outcomes in patients with observed high risk choroidal nevi vs. immediately treated uveal melanomas

Amna Ali; Ankit Kadakia; Alice Z Chuang; Catherine Bailey; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2255.

ARVO Annual Meeting Abstract June 2024

Co-occurrence of uveal melanoma driver mutations: a case series

Henry Chang Skrehot; Amer Alsoudi; Arash Delavar; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2252.

Retina June 2023

Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes

PDF

Stephanie Trejo Corona; Cecilia Villanueva Boone; Amna M. Ali; Chelsey Moore; Alexandra Brown; Jose Munoz; Thomas Aaberg, Jr.; Amy C. Schefler; on behalf of the ARRT Study Group
TAGS: aflibercept, cohort studies, radiation retinopathy, randomized controlled trial, injections, visual acuity
Invest. Ophthalmol. Vis. Sci.. 2023; 64(7):35. https://doi.org/10.1167/iovs.64.7.35

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Characterization of neutropenia following intra-arterial chemotherapy (IAC) in retinoblastoma

Debora Hana Lee; Matthew Parvus; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1274.

ARVO Annual Meeting Abstract June 2023

Multiplying Brown Spots

Amer Alsoudi; Matthew Parvus; Jose Pulido; Patricia Chevez-Barrios; Bin Teh; Eric Bernicker; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):907.

ARVO Annual Meeting Abstract June 2022

Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes

Stephanie Trejo Corona; Cecilia Villanueva Boone; Chelsey Moore; Alex Brown; Jose Munoz; Thomas Aaberg Jr.; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):0001.

ARVO Annual Meeting Abstract June 2022

Morphological Biomarkers Related to Visual Acuity in Patients with Radiation Retinopathy Treated with Intravitreal Ranibizumab

Amy C Schefler; Stephanie Trejo; Hannah Yu; Chelsey Moore

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2356 – A0025.

ARVO Annual Meeting Abstract June 2022

Comparison of Tumor Size at Presentation and Genomics in Uveal Melanoma Patients Before and After the COVID-19 Pandemic

Naomi Hasegawa; Alex Rusakevich; Eric Bernicker; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2345 – A0014.

ARVO Annual Meeting Abstract June 2021

Clinical characteristics and gene expression profile status in young patients with uveal melanoma: Collaborative Ocular Oncology Group study #2 (COOG2) study

Ekaterina Semenova; Christina Decatur; Amy C Schefler; Thomas Aaberg; Brian Marr; Zelia Correa; J. William Harbour; Prithvi Mruthyunjaya; Miguel Materin

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):39.

ARVO Annual Meeting Abstract June 2021

Design, Methods, and Rationale for the Collaborative Ocular Oncology Group 2 (COOG2) Study

Amy C Schefler; Prithvi Mruthyunjaya; Christina Decatur; Miguel Materin; Zelia Correa; Thomas Aaberg; Brian Marr; Katya Semenova; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2870.

ARVO Annual Meeting Abstract June 2020

Cytomorphology: A Prognostic Adjuvant to Genomic Testing in Uveal Melanoma in "Mismatched" Cases

Amy C Schefler; Brandon Nguyen; Patricia Chevez-Barrios; Maria Elena Bretana; Eric Bernicker

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2846.

ARVO Annual Meeting Abstract June 2020

Interim analysis of small choroidal melanocytic tumors with and without identifiable driver mutations

Ezekiel Weis; Prithvi Mruthyunjaya; Amy C Schefler; Zelia Correa; Thomas M Aaberg; Michael Durante; Christina Decatur; J William Harbour

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2847.

ARVO Annual Meeting Abstract June 2020

Impact of different initial systemic staging imaging strategies on metastasis detection in uveal melanoma patients: The Melanoma of the Uvea Staging Imaging Consortium (MUSIC) Study

Anthony B Daniels; Katherine S. Peters; Mark P Breazzano; William Choi; Jeanette Du; Nathan Law; Audra Miller; Max Aveis; Suleyman Ciftci; Amy C Schefler; Hakan Demirci; Alison Skalet; Yevgeniy Shildkrot; Stephen Deppen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4027.

ARVO Annual Meeting Abstract June 2020

A Phase 1b/2 Open-label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma

Prithvi Mruthyunjaya; Amy C Schefler; Ivana K Kim; Christopher Bergstrom; Hakan Demirci; Tony Tsai; Abdhish R Bhavsar; Antonio Capone; Brian Marr; Tara A McCannel; Cameron Javid; Peter G Hovland; Michael I. Seider; Cadmus Rich; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4025.

ARVO Annual Meeting Abstract July 2019

Two year results of a phase 1b/2 open-label clinical trial of AU-011 for the treatment of small to medium choroidal melanoma

Tara A McCannel; Abdhish Bhavsar; Antonio Capone; Hakan Demirici; Ivana K Kim; Brian Marr; Cadmus Rich; Amy C Schefler; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):719.

ARVO Annual Meeting Abstract July 2019

Randomized Trial of Monthly versus PRN intravitreal injection of ranibizumab with and without PRN targeted panretinal photocoagulation (TRP) for radiation-induced macular edema: RRR Two year Anatomic Outcomes

Amy C Schefler; Rajiv Anand; Timothy Fuller; Dwain Fuller; Ryan S Kim

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):722.

ARVO Annual Meeting Abstract July 2019

Randomized Trial of Monthly versus PRN intravitreal injection of ranibizumab with and without PRN targeted panretinal photocoagulation (TRP) for radiation-induced macular edema: RRR 2-year Visual Acuity Outcomes

Ryan Kim; Rajiv Anand; Dwain Fuller; Timothy Fuller; Maria Bretana; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):723.

ARVO Annual Meeting Abstract July 2018

Trends in radiation practices for female ocular oncologists in North America

Sona Shah; Zelia M Correa; Amy C Schefler; Kaitlin Kogachi; Mary E Aronow; Sonia Callejo; Shelley Day; Katherine Paton; Isabella Phan; Carol L Shields; Alison Skalet; Richard Jennelle; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3623.

ARVO Annual Meeting Abstract July 2018

Ranibizumab for Radiation Retinopathy (RRR): A Prospective, Multicenter Trial of Monthly versus PRN Dosing for Radiation Retinopathy-Related Cystoid Macular Edema

Amy C Schefler; Dwain Fuller; Rajiv Anand; Timothy Fuller; Maria Elena Bretana; Cassandra Cone; Chelsey Moore; Ryan Kim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5987.

ARVO Annual Meeting Abstract July 2018

Real-world plaque brachytherapy clinical practices among Ocular Oncology Study Consortium treatment centers

prithvi Mruthyunjaya; Christina Binder; Amy C Schefler; Michael Seider; Alison Skalet

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3624.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Metastatic outcomes in patients with observed high risk choroidal nevi vs. immediately treated uveal melanomas

Co-occurrence of uveal melanoma driver mutations: a case series

Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes

Characterization of neutropenia following intra-arterial chemotherapy (IAC) in retinoblastoma

Multiplying Brown Spots

Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes

Morphological Biomarkers Related to Visual Acuity in Patients with Radiation Retinopathy Treated with Intravitreal Ranibizumab

Comparison of Tumor Size at Presentation and Genomics in Uveal Melanoma Patients Before and After the COVID-19 Pandemic

Clinical characteristics and gene expression profile status in young patients with uveal melanoma: Collaborative Ocular Oncology Group study #2 (COOG2) study

Design, Methods, and Rationale for the Collaborative Ocular Oncology Group 2 (COOG2) Study

Cytomorphology: A Prognostic Adjuvant to Genomic Testing in Uveal Melanoma in "Mismatched" Cases

Interim analysis of small choroidal melanocytic tumors with and without identifiable driver mutations

Impact of different initial systemic staging imaging strategies on metastasis detection in uveal melanoma patients: The Melanoma of the Uvea Staging Imaging Consortium (MUSIC) Study

A Phase 1b/2 Open-label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma

Two year results of a phase 1b/2 open-label clinical trial of AU-011 for the treatment of small to medium choroidal melanoma

Randomized Trial of Monthly versus PRN intravitreal injection of ranibizumab with and without PRN targeted panretinal photocoagulation (TRP) for radiation-induced macular edema: RRR Two year Anatomic Outcomes

Randomized Trial of Monthly versus PRN intravitreal injection of ranibizumab with and without PRN targeted panretinal photocoagulation (TRP) for radiation-induced macular edema: RRR 2-year Visual Acuity Outcomes

Trends in radiation practices for female ocular oncologists in North America

Ranibizumab for Radiation Retinopathy (RRR): A Prospective, Multicenter Trial of Monthly versus PRN Dosing for Radiation Retinopathy-Related Cystoid Macular Edema

Real-world plaque brachytherapy clinical practices among Ocular Oncology Study Consortium treatment centers

To View More...

You must be signed into an individual account to use this feature.